NCT06295523

Brief Summary

The purpose of this study is to investigate thermoregulatory responses in older individuals with COPD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

October 24, 2025

Status Verified

October 1, 2025

Enrollment Period

1.8 years

First QC Date

February 26, 2024

Last Update Submit

October 22, 2025

Conditions

Keywords

COPDheat wavethermoregulation

Outcome Measures

Primary Outcomes (4)

  • Core body temperature

    Core body temperature will be measure from gastrointestinal temperature via an ingestible telemetric pill

    Prior to and throughout each simulated heat wave exposure, an average of 480 minutes

  • Forced expiratory volume (FEV1)

    FEV1 will be assessed via spirometry

    Prior to, during, and after each simulated heat wave exposure, approximately 10 min each

  • Forced vital capacity (FVC)

    FVC will be assessed via spirometry

    Prior to, during, and after each simulated heat wave exposure, approximately 10 min each

  • FEV1/FVC ratio

    The ratio of forced expiratory volume and forced vital capacity will be assessed via spirometry

    Prior to, during, and after each simulated heat wave exposure, approximately 10 min each

Study Arms (2)

Experimental: Very hot and dry

EXPERIMENTAL

Subjects will be exposed to 3 hours in a climate chamber set to approximately 47 deg C and 15% relative humidity, which reflects a very hot and dry heat wave condition similar to the 2018 Los Angeles heat wave. Two visits will be required to complete this arm, with one visit including water spray for cooling.

Other: Water SprayOther: Control

Experimental: Hot and humid

EXPERIMENTAL

Subjects will be exposed to 3 hours in a climate chamber set to approximately 41 deg C and 40% relative humidity, which reflects hot and humid heat wave similar to the 1995 Chicago heat wave. Two visits will be required to complete this arm, with one visit including water spray for cooling.

Other: Water SprayOther: Control

Interventions

Participants will receive water spraying on their body throughout the climate chamber exposure.

Experimental: Hot and humidExperimental: Very hot and dry
ControlOTHER

Participants will NOT receive water spraying on their body throughout the climate exposure.

Experimental: Hot and humidExperimental: Very hot and dry

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years old or older
  • Diagnosis of COPD

You may not qualify if:

  • Known heart disease
  • Other chronic medical conditions requiring regular medical therapy including cancer, diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia etc
  • Abnormality detected on routine screening suggestive of provokable ischemia or previously undetected cardiac disease or resting left bundle branch block on screening electrocardiogram
  • Current smokers
  • Participant with a body mass index ≥31 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Health Presbyterian Hospital Dallas

Dallas, Texas, 75231, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveHyperthermia

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBody Temperature ChangesSigns and SymptomsHeat Stress DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Internal Medicine

Study Record Dates

First Submitted

February 26, 2024

First Posted

March 6, 2024

Study Start

January 1, 2024

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

October 24, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Locations